Mood, cognition and EEG changes during interferon α (alpha-IFN) treatment for chronic hepatitis C

Journal of Affective Disorders

Volumn 84, Issue 1, 2005, Pages 93-98

  Amodio, Piero ^a   De Toni, Enrico N ^a   Cavalletto, Luisa ^a   Mapelli, Daniela ^b   Bernardinello, Elisabetta ^a   Del Piccolo, Franco ^a   Bergamelli, Cristina ^b   Costanzo, Raffaella ^b   Bergamaschi, Federica ^b   Poma, Stefano Zanone ^b   Chemello, Liliana ^a   Gatta, Angelo ^a,b,c   Perini, Giulia ^b  

^a University Policlinic   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c Reg Proj on Chronic Liver Disease   (Italy)

Author keywords

interferon; Chronic hepatitis C; Cognition; Depression; EEG

Indexed keywords

ALPHA INTERFERON; RIBAVIRIN;

ANXIETY DISORDER; ARTICLE; BECK DEPRESSION INVENTORY; COGNITION; DEPRESSION; DRUG DOSE REDUCTION; ELECTROENCEPHALOGRAM; HAMILTON SCALE; HEPATITIS C; HUMAN; MOOD; NEUROTOXICITY; PRIORITY JOURNAL; THETA RHYTHM;

ADOLESCENT; ADULT; AFFECT; ANTIVIRAL AGENTS; ANXIETY; COGNITION; COGNITION DISORDERS; DEPRESSION; ELECTROENCEPHALOGRAPHY; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; SEVERITY OF ILLNESS INDEX;

EID: 19944408937     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2004.09.004     Document Type: Article

References (45)

1. P. Amodio, P. Marchetti, and F. Del Piccolo Study on the Sternberg paradigm in cirrhotic patients without overt hepatic encephalopathy Metab. Brain Dis. 13 1998 159 172
2. P. Amodio, P. Marchetti, and F. Del Piccolo Spectral versus visual EEG analysis in mild hepatic encephalopathy Clin. Neurophysiol. 110 1999 1334 1344
3. P. Amodio, F. Del Piccolo, and P. Marchetti Clinical features and survival of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests Hepatology 29 1999 1662 1667
4. G. Barrett Clinical application of event-related potentials in dementing illness: issues and problems Int. J. Psychophysiol. 37 2000 49 53
5. A.T. Beck, and Ch. Word An inventory for measuring depression Arch. Gen. Psychiatry 4 1961 561 571
6. S. Belville, I. Peretz, and D. Malefant Examination of the working memory components in normal aging and dementia of the Alzheimer type Neuropsychologia 34 1996 195 207
7. A.L. Benton, and K. Hamsher Multilingual Aphasia Examination 1976 University of Iowa Press Iowa City
8. L. Capuron, and A. Ravaud Prediction of the depressive effects of interferon alfa therapy by the patients initial affective state N. Engl. J. Med. 340 1999 1370
9. L. Capuron, A. Ravaud, and R. Dantzer Timing and specificity of the cognitive changes induced by interleukin-2 and interferon-alpha treatments in cancer patients Psychosom. Med. 63 2001 376 386
10. L. Capuron, G. Neurauter, D.L. Musselman, D.H. Lawson, C.B. Nemeroff, and D. Fuchs Interferon-alpha-induced changes in tryptophan metabolism: relationship to depression and paroxetine treatment Biol. Psychiatry 54 2003 906 914
11. L. Chemello, L. Cavalletto, and E. Bernardinello The effect of interferon alfa and ribavirin combination therapy in naive patients with chronic hepatitis C J. Hepatol. 23 Suppl. 2 1995 8 12
12. E. Dieperink, M. Willenbring, and S.B. Ho Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: a review Am. J. Psychiatry 157 2000 867 876
13. E. Dieperink, S.B. Ho, P. Thuras, and M.L. Willenbring A prospective study of neuropsychiatric symptoms associated with interferon-alpha-2b and ribavirin therapy for patients with chronic hepatitis C Psychosomatics 44 2003 104 112
14. M.S. Exton, J. Baase, V. Pithan, M.U. Goebel, and M. Schedlowski Neuropsychological performance and mood states following acute interferon-beta-1b administration in healthy males Neuropsychobiology 45 2002 199 204
15. G. Fattovich, G. Giustina, and S. Favarato A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alfa interferon J. Hepatol. 24 1996 38 47
16. M. Hamilton The assessment of anxiety states by rating Br. J. Med. Psychol. 32 1959 50 55
17. M. Hamilton A rating scale for depression J. Neurol. Neurosurg. Psychiatry 23 1960 56 62
18. P. Hauser, J. Khosla, H. Aurora, J. Laurin, M.A. Kling, and J. Hill A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C Mol. Psychiatry 7 2002 942 947
19. M.L. Hensley, B. Peterson, and R.T. Silver Risk factors for severe neuropsychiatric toxicity in patients receiving interferon alfa-2b and low-dose cytarabine for chronic myelogenous leukemia: analysis of Cancer and Leukemia Group B 9013 J. Clin. Oncol. 18 2000 1301 1308
20. C.M. Hunt, J.A. Dominitz, and B.P. Bute Effect of interferon-alpha treatment of chronic hepatitis C on health-related quality of life Dig. Dis. Sci. 42 1997 2482 2486
21. S. Kamei, T. Sakai, and M. Matsuura Alterations of quantitative EEG and mini-mental state examination in interferon-alpha-treated hepatitis C Eur. Neurol. 48 2002 102 107
22. M.R. Kraus, A. Shaefer, H. Faller, H. Csef, and M. Scheurlen Paroxetine for the treatment of interferon-alpha-induced depression in chronic hepatitis C Aliment. Pharmacol. Ther. 16 2002 1091 1099
23. M.R. Kraus, A. Schäfer, H. Faller, H. Csef, and M. Scheurlen Psychiatric symptoms in patients with chronic hepatitis C receiving interferon alfa-2b therapy J. Clin. Psychiatry 64 2003 708 714
24. M. Maes, S. Bonaccorso, V. Marino, A. Puzella, M. Pasquini, M. Biondi, M. Arturi, C. Almerighi, and H. Meltzer Treatment with interferon-alpha (alpha-IFN) of hepatitis induces lower serum dipeptidyl peptidase IV activity, which is related to alpha-IFN induced depressive and anxiety symptoms and immune activation Mol. Psychiatry 6 2001 475 480
25. M.P. Manns, J.G. McHutchinson, and S.C. Gordon Peginterferon alpha 2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial Lancet 358 2001 958 965
26. S. Mondini, D. Mapelli, and A. Vestri Esame Neuropsicologico Breve (ENB) 2003 Raffaello Cortina Padova
27. R.T. Mulder, M. Ang, and B. Chapman Interferon treatment is not associated with a worsening of psychiatric symptoms in patients with hepatitis C J. Gastroenterol. Hepatol. 15 2000 300 303
28. T. Otsubo, H. Miyaoka, T. Otsubo, K. Kamijima, M. Ishii, M. Onuki, and K. Mitamura Depression from interferon therapy in patients with hepatitis C Am. J. Psychiatry 156 1999 1120
29. C.M. Pariante, M.G. Orru, and A. Baita Treatment with interferon-alpha in patients with chronic hepatitis and mood or anxiety disorders Lancet 354 1999 131 132
30. M.A. Pavol, C.A. Meyers, and J.L. Rexer Pattern of neurobehavioral deficits associated with interferon alfa therapy for leukemia Neurology 45 1995 947 950
31. L.R. Peterson, and M.J. Peterson Short-term retention of individual verbal items J. Exp. Psychol. 68 1959 193 198
32. J.R. Quesada, M. Talpaz, and A. Rios Clinical toxicity of interferons in cancer patients: a review J. Clin. Oncol. 4 1986 234 243
33. R.M. Reitan Validity of the trail making test as an indicator of organic brain damage Percept. Mot. Skills 8 1958 271 276
34. A. Rey, and A.L. Benton Examen de afasia multilingue 1991 AJA Associates Iowa City, IA
35. M. Shaefer, F. Schmidt, C. Folwaczny, R. Lorenz, G. Martin, and N. Schindlbeck Adherence and mental side effects during hepatitis C treatment with interferon alpha and ribavirin in psychiatric risk groups Hepatology 37 2003 443 451
36. T. Shallice, and M.E. Evans The involvement of the frontal lobes in cognitive estimation Cortex 14 1978 294 303
37. Sheehan, D.V., Lecrubier, Y. 1994. Mini International Neuropsychiatric Interview (M.I.N.I.). University of South Florida Institute for Research in Psychiatry, Tampa, Florida and INSERM - Hopital de la Salpétrière, Paris, France.
38. A. Smith, D. Tyrrell, and K. Coyle Effects of interferon alpha on performance in man: a preliminary report Psychopharmacology 96 1988 414 416
39. C.D. Spielberg Manual for the State-Trait Anxiety Inventory 1983 Consulting Psychologists Press Palo Alto, CA Revised edition
40. S. Sternberg Memory-scanning: mental processes revealed by reaction-time experiments Am. Sci. 57 1969 421 457
41. J.R. Stroop Studies of interference in serial verbal reactions J. Exp. Psychol. 18 1935 643 662
42. P.C. Trask, P. Esper, and M. Riba Psychiatric side effects of interferon therapy: prevalence, proposed mechanisms, and future directions J. Clin. Oncol. 18 2000 2316 2326
43. A.D. Valentine, C.A. Meyers, and M.A. Kling Mood and cognitive side effects of interferon-alpha therapy Semin. Oncol. 25 1998 39 47
44. C.S. von Ammon Depression in the medically ill. Critical issues in diagnostic assessment Psychosomatics 36 1995 48 59
45. D. Wechsler A standardized memory scale for clinical use J. Psychol. 19 1945 87 95